# US 2013/0253402 A1 · Ocular delivery systems and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253402 A1
- Document ID: US20130253402A1
- Status: Published application
- Kind: A1
- Application number: 13/644,769
- Filed: 2012-10-04
- Published: 2013-09-26
- Earliest claimed: 2012-03-20
- Assignees: Sight Sciences, Inc.
- Applicants: Sight Sciences, Inc.
- Inventors: David Y. BADAWI; Daniel O'KEEFFE; Paul BADAWI
- Web page: https://patentgrep.com/patent/US20130253402A1

## CPC

- A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61F 9/007: Methods or devices for eye surgery
- A61F 9/00736: {Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments (A61F9/008 takes precedence)}
- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Described here are systems and methods for accessing Schlemm's canal and for delivering an ocular device or fluid composition therein. The ocular devices may maintain the patency of Schlemm's canal without substantially interfering with transmural fluid flow across the canal. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. Tools for disrupting these tissues and minimally invasive methods for treating medical conditions associated with elevated intraocular pressure, including glaucoma, are also described.

## Claims

### Claim 1

An implant-free method for treating conditions of the eye comprising:
advancing a conduit into Schlemm's canal, where the conduit has been loaded with a volume of viscoelastic fluid; and
delivering the viscoelastic fluid into Schlemm's canal at a volume sufficient to disrupt the trabeculocanalicular tissues to reduce intraocular pressure.

### Claim 2 (depends on 1)

The implant-free method of claim 1, wherein the volume of delivered viscoelastic fluid is between about 2 μl to about 8 μl.

### Claim 3 (depends on 2)

The implant-free method of claim 2, wherein the volume of delivered viscoelastic fluid is about 4 μl.

### Claim 4 (depends on 1)

The implant-free method of claim 1, wherein the volume of viscoelastic fluid is delivered while withdrawing the conduit from Schlemm's canal.

### Claim 5 (depends on 1)

The implant-free method of claim 1, wherein the conduit is loaded with the viscoelastic fluid immediately prior to advancing the conduit into Schlemm's canal.

### Claim 6 (depends on 1)

The implant-free method of claim 1, wherein the conduit is advanced in both clockwise and counterclockwise directions in Schlemm's canal.

### Claim 7 (depends on 1)

The implant-free method of claim 1, wherein the conduit is advanced about a 360 degree arc of Schlemm's canal.

### Claim 8 (depends on 1)

The implant-free method of claim 1, wherein the conduit is advanced about a 180 degree arc of Schlemm's canal.

### Claim 9 (depends on 1)

The implant-free method of claim 1, wherein the conduit is advanced from a single access point in Schlemm's canal.

### Claim 10 (depends on 6)

The implant-free method of claim 6, wherein the conduit is advanced from a single access point in Schlemm's canal.

### Claim 11 (depends on 1)

The implant-free method of claim 1, wherein the conduit is advanced from a plurality of access points in Schlemm's canal.

### Claim 12 (depends on 6)

The implant-free method of claim 6, wherein the conduit is advanced from a plurality of access points in Schlemm's canal.

### Claim 13 (depends on 1)

The implant-free method of claim 1, wherein the volume of viscoelastic fluid dilates Schlemm's canal.

### Claim 14 (depends on 1)

The implant-free method of claim 1, wherein the trabeculocanalicular tissues comprise at least a portion of the trabecular meshwork or juxtacanalicular tissue.

### Claim 15 (depends on 1)

The implant-free method of claim 1, wherein the trabeculocanalicular tissues comprise collector channels.

### Claim 16 (depends on 1)

The implant-free method of claim 1, wherein the conduit has an outer diameter between about 150 and about 500 microns.

### Claim 17 (depends on 16)

The implant-free method of claim 16, wherein the conduit has a diameter of about 240 microns.

### Claim 18 (depends on 1)

The implant-free method of claim 1, wherein the viscoelastic fluid comprises hyaluronic acid, chondroitin sulfate, cellulose, or salts, derivatives, or mixtures thereof.

### Claim 19 (depends on 18)

The implant-free method of claim 18, wherein the viscoelastic fluid comprises sodium hyaluronate.

### Claim 20 (depends on 1)

The implant-free method of claim 1, wherein the eye conditions are glaucoma, pre-glaucoma, or ocular hypertension.

### Claim 21

A method for reducing intraocular pressure comprising:
a) advancing a cannula at least partially through the anterior chamber of the eye;
b) entering Schlemm's canal at a single access point using the cannula; and
c) delivering a volume of a viscoelastic fluid through a conduit slidable within, and extendable from, the cannula, sufficient to disrupt the structure of Schlemm's canal and surrounding tissues to reduce intraocular pressure.

### Claim 22 (depends on 21)

The method of claim 21, wherein the volume of the delivered viscoelastic fluid is between about 2 μl to about 8 μl.

### Claim 23 (depends on 22)

The method of claim 22, wherein the volume of the delivered viscoelastic fluid is about 4 μl.

### Claim 24 (depends on 21)

The method of claim 21, wherein the conduit is advanced about a 360 degree arc of Schlemm's canal from the single access point.

### Claim 25 (depends on 24)

The method of claim 24, wherein the viscoelastic fluid is delivered along the 360 degree arc during withdrawal of the conduit from Schlemm's canal.

### Claim 26 (depends on 21)

The method of claim 21, wherein the conduit is advanced about a 180 degree arc of Schlemm's canal from the single access point.

### Claim 27 (depends on 26)

The method of claim 26, wherein the viscoelastic fluid is delivered along the 180 degree arc during withdrawal of the conduit from Schlemm's canal.

### Claim 28 (depends on 21)

The method of claim 21, wherein the conduit is advanced about a 180 degree arc of Schlemm's canal in both clockwise and counterclockwise directions from the single access point.

### Claim 29 (depends on 28)

The method of claim 28, wherein the viscoelastic fluid is delivered along the 180 degree arc during withdrawal of the conduit from Schlemm's canal.

### Claim 30 (depends on 21)

The method of claim 21, wherein the conduit is advanced about a 90 degree arc of Schlemm's canal from the single access point.

### Claim 31 (depends on 30)

The method of claim 30, wherein the viscoelastic fluid is delivered along the 90 degree arc during withdrawal of the conduit from Schlemm's canal.

### Claim 32 (depends on 21)

The method of claim 21, wherein the viscoelastic fluid comprises hyaluronic acid, chondroitin sulfate, cellulose, or salts, derivatives, or mixtures thereof.

### Claim 33 (depends on 32)

The method of claim 32, wherein the viscoelastic fluid comprises sodium hyaluronate.

### Claim 34 (depends on 21)

The method of claim 21, wherein the conduit has an outer diameter of about 300 microns to about 500 microns.

### Claim 35 (depends on 34)

The method of claim 34, wherein the conduit has an outer diameter of about 240 microns.

### Claim 36 (depends on 21)

The method of claim 21, wherein the step of disrupting comprises increasing the porosity of the trabecular meshwork or stretching the trabecular meshwork using the viscoelastic fluid.

### Claim 37 (depends on 21)

The method of claim 21, wherein the step of disrupting comprises forming microtears in the juxtacanalicular tissue using the viscoelastic fluid.

### Claim 38 (depends on 21)

The method of claim 21, wherein the step of disrupting comprises dilating Schlemm's canal using the viscoelastic fluid.

### Claim 39 (depends on 21)

The method of claim 21, wherein the step of disrupting comprises removing septae from Schlemm's canal using the viscoelastic fluid.

### Claim 40 (depends on 21)

The method of claim 21, wherein the step of disrupting comprises dilating collector channels using the viscoelastic fluid.

### Claim 41 (depends on 21)

The method of claim 21, wherein the reduction in intraocular pressure treats glaucoma, pre-glaucoma, or ocular hypertension.

### Claim 42 (depends on 21)

The method of claim 21, further comprising delivering an implant within Schlemm's canal to maintain patency of the canal.

### Claim 43 (depends on 42)

The method of claim 42, wherein the implant comprises a helical support.

### Claim 44 (depends on 43)

The method of claim 43, wherein the helical support comprises at least one fenestration.

### Claim 45 (depends on 21)

The method of claim 21, further comprising delivering energy to modify the structure of Schlemm's canal and surrounding tissues.

### Claim 46 (depends on 21)

The method of claim 21, wherein the volume of viscoelastic fluid is continuously delivered through the conduit to disrupt the structure of Schlemm's canal and surrounding tissues.

### Claim 47 (depends on 21)

The method of claim 21, wherein the conduit is part of an ocular delivery device comprising a universal handle.

### Claim 48 (depends on 47)

The method of claim 47, wherein the universal handle comprises a wheeled drive assembly.

### Claim 49 (depends on 48)

The method of claim 48, wherein the wheeled drive assembly comprises a single rotatable component.

### Claim 50 (depends on 48)

The method of claim 48, wherein the wheeled drive assembly comprises a plurality of rotatable components.

### Claim 51 (depends on 21)

The method of claim 21, wherein the viscoelastic fluid is loaded into the ocular delivery device immediately prior to advancing the cannula into the eye.

### Claim 52

A method for treating conditions of the eye comprising:
a) entering Schlemm's canal using a conduit extendable from a single-operator controlled handle, the handle comprising a fluid reservoir; and
b) delivering a volume of a viscoelastic fluid from the fluid reservoir through the conduit by increasing pressure within the fluid reservoir,
wherein the volume of delivered viscoelastic fluid is sufficient to disrupt the structure of Schlemm's canal and surrounding tissues to reduce intraocular pressure.

### Claim 53 (depends on 52)

The method of claim 52, wherein the viscoelastic fluid is delivered about at least a 360 degree arc of Schlemm's canal.

### Claim 54 (depends on 52)

The method of claim 52, wherein the viscoelastic fluid is delivered about at least a 180 degree arc of Schlemm's canal.

### Claim 55 (depends on 52)

The method of claim 52, wherein the viscoelastic fluid is delivered about at least a 90 degree arc of Schlemm's canal.

### Claim 56 (depends on 52)

The method of claim 52, wherein the step of delivering occurs by advancing the conduit in both the clockwise and counterclockwise directions with the same single-operator controlled handle.

### Claim 57 (depends on 52)

The method of claim 52, wherein the viscoelastic fluid comprises hyaluronic acid, chondroitin sulfate, cellulose, or salts, derivatives, or mixtures thereof.

### Claim 58 (depends on 57)

The method of claim 57, wherein the viscoelastic fluid comprises sodium hyaluronate.

### Claim 59 (depends on 52)

The method of claim 52, wherein the conduit has an outer diameter between about 300 microns and about 500 microns.

### Claim 60 (depends on 59)

The method of claim 59, wherein the conduit has an outer diameter of about 240 microns.

### Claim 61 (depends on 52)

The method of claim 52, wherein the step of disrupting comprises increasing the porosity of the trabecular meshwork or stretching the trabecular meshwork using the viscoelastic fluid.

### Claim 62 (depends on 52)

The method of claim 52, wherein the step of disrupting comprises forming microtears in the juxtacanalicular tissue using the viscoelastic fluid.

### Claim 63 (depends on 52)

The method of claim 52, wherein the step of disrupting comprises dilating Schlemm's canal using the viscoelastic fluid.

### Claim 64 (depends on 52)

The method of claim 52, wherein the step of disrupting comprises removing septae from Schlemm's canal using the viscoelastic fluid.

### Claim 65 (depends on 52)

The method of claim 52, wherein the step of disrupting comprises dilating collector channels using the viscoelastic fluid.

### Claim 66 (depends on 52)

The method of claim 52, wherein the reduction in intraocular pressure treats glaucoma, pre-glaucoma, or ocular hypertension.

### Claim 67 (depends on 52)

The method of claim 52, further comprising delivering an implant within Schlemm's canal to maintain patency of the canal.

### Claim 68 (depends on 67)

The method of claim 67, wherein the implant comprises a helical support.

### Claim 69 (depends on 68)

The method of claim 68, wherein the helical support comprises at least one fenestration.

### Claim 70 (depends on 52)

The method of claim 52, further comprising delivering energy to modify the structure of Schlemm's canal and surrounding tissues.

### Claim 71 (depends on 52)

The method of claim 52, wherein the volume of viscoelastic fluid is continuously delivered through the conduit to disrupt the structure of Schlemm's canal and surrounding tissues.

### Claim 72 (depends on 52)

The method of claim 52, wherein the single-operator controlled handle comprises a wheeled drive assembly.

### Claim 73 (depends on 72)

The method of claim 72, wherein the wheeled drive assembly comprises a single rotatable component.

### Claim 74 (depends on 72)

The method of claim 72, wherein the wheeled drive assembly comprises a plurality of rotatable components.

### Claim 75 (depends on 52)

The method of claim 52, wherein the viscoelastic fluid is loaded into the fluid reservoir prior to advancement of the conduit.

### Claim 76

A device for delivering fluids comprising:
a cannula;
a conduit slidably disposed within, and advanceable distally from, the cannula;
a handle coupled to the cannula, wherein a portion of the handle defines a fluid reservoir; and
a linear gear moveable to advance a fluid from the fluid reservoir through the conduit.

### Claim 77 (depends on 76)

The device of claim 76, wherein the conduit has a diameter between about 300 microns and about 500 microns.

### Claim 78 (depends on 77)

The device of claim 77, wherein the conduit has a diameter of about 240 microns.

### Claim 79 (depends on 76)

The device of claim 76, wherein the conduit comprises a plurality of openings spaced along at least a portion of its axial length.

### Claim 80 (depends on 76)

The device of claim 76, wherein a distal end of the conduit comprises a cut out configured as a half tube.

### Claim 81 (depends on 76)

The device of claim 76, wherein the moveable linear gear is capable of pressurizing the fluid to deliver the fluid from the fluid reservoir through the conduit.

### Claim 82 (depends on 76)

The device of claim 76, wherein the linear gear is coupled to a single rotatable component in the handle.

### Claim 83 (depends on 76)

The device of claim 76, wherein the linear gear is coupled to a plurality of rotatable components in the handle.

### Claim 84 (depends on 76)

The device of claim 76, wherein the handle comprises a preloaded fluid reservoir, the preloaded fluid reservoir comprising a viscoelastic fluid.

### Claim 85 (depends on 84)

The device of claim 84, wherein the viscoelastic fluid comprises hyaluronic acid, chondroitin sulfate, cellulose, or salts, derivatives, or mixtures thereof.

### Claim 86 (depends on 85)

The device of claim 85, wherein the viscoelastic fluid comprises sodium hyaluronate.

### Claim 87 (depends on 76)

The device of claim 76, wherein the fluid comprises a viscoelastic fluid.

### Claim 88 (depends on 87)

The device of claim 87, wherein the viscoelastic fluid comprises hyaluronic acid, chondroitin sulfate, cellulose, or salts, derivatives, or mixtures thereof.

### Claim 89 (depends on 88)

The device of claim 88, wherein the viscoelastic fluid comprises sodium hyaluronate.
